Cost-effectiveness analysis of durvalumab as a maintenance treatment for patients with locally advanced, unresectable, stage Ⅲ nsclc in china

• Xiaotong Jiang,

  Roles Writing – original draft

  Affiliation Institute of Medical Information, Chinese Academy of Medical Sciences, Beijing, China

  ⨯
• Jinyu Chen ,

  Roles Investigation, Methodology, Writing – original draft, Writing – review & editing

  * E-mail: sycjy1015@163.com

  Affiliations China Health Economics Association, Beijing, China, National Center for Medicine and Health Technology Assessment, Beijing, China

  https://orcid.org/0000-0002-0534-7543

  ⨯
• Min Zheng,

  Roles Software, Writing – original draft

  Affiliation Shenyang Pharmaceutical University, Shenyang, China

  ⨯
• Hanxue Jia

  Roles Investigation, Writing – original draft

  Affiliation Shenyang Pharmaceutical University, Shenyang, China

  ⨯